Literature DB >> 6475427

[Pancreatic metastases of nephro-epitheliomas. Apropos of 2 cases].

J M Py, J P Arnaud, J Cinqualbre, M Adloff, C Bollack.   

Abstract

Pancreatic metastasis from clear cell carcinoma of the kidney are exceptional (1 to 3 per cent). Twelve cases have been found in the literature, to which our two observations must be add. Intestinal haemorrhage rule the clinical signs. The complementary arteriography is a very good investigation. Surgery with excision may be effect when a solitary metastasis to the pancreas exist. We can argue about chemotherapy when there is a metastatic dissemination.

Entities:  

Mesh:

Year:  1984        PMID: 6475427

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  5 in total

Review 1.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

Review 2.  Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism?

Authors:  Franz Sellner
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

3.  Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases.

Authors:  José Celso Ardengh; César Vivian Lopes; Rafael Kemp; Filadélfio Venco; Eder Rios de Lima-Filho; José Sebastião dos Santos
Journal:  BMC Gastroenterol       Date:  2013-04-11       Impact factor: 3.067

Review 4.  Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations.

Authors:  Franz Sellner
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

Review 5.  Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.

Authors:  Franz Sellner; Sabine Thalhammer; Martin Klimpfinger
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.